Market Place
Sourcing Support
Cosette’s Generics Ciprofloxacin HCl Receives Approval in US
10 Nov 2025 //
FDA
Alembic’s Generics Dasatinib Receives Approval In US
06 Nov 2025 //
FDA
Steriscience’s Generics Doxycycline Receives Approval in US
06 Nov 2025 //
FDA
Alembic’s Generics Sumatriptan Succinate Receives Approval in US
06 Nov 2025 //
FDA
Umedica’s Generics Diclofenac Sodium Receives Approval in US
05 Nov 2025 //
FDA
Laurus’s Generics Macitentan Receives Approval in US
05 Nov 2025 //
FDA
Ascent’s Generics Sodium Oxybate Receives Approval in US
05 Nov 2025 //
FDA
MSN’s Generics Irbesartan Receives Approval in US
04 Nov 2025 //
FDA
Rising’s Generics Sulfasalazine Receives Approval in US
04 Nov 2025 //
FDA
MSN’s Generics Mirabegron Receives Approval in US
04 Nov 2025 //
FDA
Amneal’s Generics Phytonadione Receives Approval in US
04 Nov 2025 //
FDA
Shandong’s Generics Isoflurane Receives Approval in US
04 Nov 2025 //
FDA
Rhodes’s Generics Maraviroc Receives Approval in US
04 Nov 2025 //
FDA
UCB’s Kygevvi Receives Approval in US
03 Nov 2025 //
FDA
SPH Zhongxi’s Generics Eslicarbazepine Receives Approval in US
03 Nov 2025 //
FDA
MSN’s Generics Vortioxetine HBr Receives Tentative Approval in US
03 Nov 2025 //
FDA
MSN’s Generics Linagliptin, Metformin HCl Receives Approval in US
03 Nov 2025 //
FDA
MSN’s Generics Linagliptin Receives Approval in US
03 Nov 2025 //
FDA
Mylan’s Generics Linagliptin Receives Approval in US
03 Nov 2025 //
FDA
Dr Reddys’s Generics Metformin HCl Receives Approval in US
03 Nov 2025 //
FDA
Aurobindo Pharma’s Generics Linagliptin Receives Approval in US
03 Nov 2025 //
FDA
Dr Reddy’s Generics Linagliptin Receives Approval in US
03 Nov 2025 //
FDA
Apotex’s Generics Axitinib Receives Approval in US
30 Oct 2025 //
FDA
Novugen’s Generics Everolimus Receives Approval in US
30 Oct 2025 //
FDA
Amneal’s Generics Neomycin Receives Approval in US
29 Oct 2025 //
FDA
Micro’s Generics Varenicline Tartrate Receives Approval in US
29 Oct 2025 //
FDA
Sciegen’s Generics Ticagrelor Receives Approval in US
28 Oct 2025 //
FDA
Novast’s Generics Drospirenone, Estradiol Receives Approval in Us
28 Oct 2025 //
FDA
Changzhou Pharm’s Generics Ticagrelor Receives Approval in US
28 Oct 2025 //
FDA
Macleods’s Generics Ticagrelor Receives Approval in US
28 Oct 2025 //
FDA
Taro’s Generics Ticagrelor Receives Approval in US
28 Oct 2025 //
FDA
Alkem’s Generics Ticagrelor Receives Approval in US
28 Oct 2025 //
FDA
Navinta’s Generics Sevelamer Carbonate Receives Approval in US
27 Oct 2025 //
FDA
Ajenat’s Generics Glycopyrrolate Receives Approval in US
27 Oct 2025 //
FDA
Carnegie’s Generics Lomustine Receives Approval in US
27 Oct 2025 //
FDA
Zenara’s Generics Tafamidis Receives Tentative Approval in Us
27 Oct 2025 //
FDA
Azurity’s Resniben Receives Tentative Approval in US
24 Oct 2025 //
FDA
Bayer Healthcare’s Lynkuet Receives Approval in US
24 Oct 2025 //
FDA
Sterinova’s Rocuronium Bromide Receives Approval in US
24 Oct 2025 //
FDA
Hikma’s Generics Atropine Sulfate Receives Approval in US
24 Oct 2025 //
FDA
MSN’s Generics Rivaroxaban Receives Approval in US
24 Oct 2025 //
FDA
Glaxosmithkline’s Biologics Blenrep Receives Approval in US
23 Oct 2025 //
FDA
Azurity’s Javadin Receives Approval in US
23 Oct 2025 //
FDA
Teva’s Generics Dalbavancin Hydrochloride Receives Approval in US
23 Oct 2025 //
FDA
Alkem’s Generics Bempedoic Acid Receives Tentative Approval in US
23 Oct 2025 //
FDA
Dr Reddys’s Generics Docosanol Receives Approval in US
23 Oct 2025 //
FDA
Royal Pharma’s Dehydrated Alcohol Receives Approval in US
23 Oct 2025 //
FDA
Caplin’s Generics Nicardipine HCl in NaCl Receives Approval in US
22 Oct 2025 //
FDA
Novitium Pharma’s Generics Lofexidine HCl Receives Approval in US
22 Oct 2025 //
FDA
Quagen’s Generics Aripiprazole Receives Approval in US
22 Oct 2025 //
FDA
Meitheal’s Contepo Receives Approval in US
22 Oct 2025 //
FDA
Taro’s Generics Trifarotene Receives Tentative Approval in US
21 Oct 2025 //
FDA
Micro’s Generics Proparacaine HCl Receives Approval in US
20 Oct 2025 //
FDA
Alkem Lab’s Generics Tolvaptan Receives Tentative Approval in US
17 Oct 2025 //
FDA
Glaukos’s Epioxa HD Receives Approval in US
17 Oct 2025 //
FDA
Glaukos’s Epioxa Receives Approval in US
17 Oct 2025 //
FDA
Novitium’s Generics Clomiphene Citrate Receives Approval in US
17 Oct 2025 //
FDA
Alembic’s Generics Triamcinolone Receives Approval in US
17 Oct 2025 //
FDA
Covis’s Ferabright Receives Approval in US
16 Oct 2025 //
FDA
BPI’s Generics Trimethobenzamide HCl Receives Approval in US
16 Oct 2025 //
FDA
